newsfilter
← Latest News
GlobeNewswire·

Caladrius Biosciences Reports Second Quarter 2021 Financial Results and Provides Business Update

BASKING RIDGE, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) ("Caladrius" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease,